Qing Mu

Title: Qing Mu - Innovator in Pharmaceutical Composition

Introduction

Qing Mu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of compounds that have therapeutic applications.

Latest Patents

Qing Mu holds a patent for a method of synthesizing S-allyl-cysteine analogues and their therapeutic application in treating myocardial infarction. This patent, which includes a pharmaceutical composition, discloses methods for producing and applying the composition to treat myocardial infarction in subjects. The composition comprises a therapeutically effective amount of at least one synthesized compound selected from a group that includes SEC, SPC, SBC, SPEC, SAC, SAMC, and SPRC, along with a pharmaceutically acceptable carrier. He has 1 patent to his name.

Career Highlights

Qing Mu is affiliated with Fudan University, where he continues to engage in research and development in the pharmaceutical field. His work focuses on innovative methods that can lead to improved therapeutic outcomes for patients suffering from serious health conditions.

Collaborations

Some of his notable coworkers include Yizhun Zhu and Qian Wang, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Qing Mu's innovative work in pharmaceutical compositions highlights his commitment to advancing medical science and improving patient care. His contributions are paving the way for new therapeutic options in treating myocardial infarction.